Clinical Trials Directory

Trials / Completed

CompletedNCT05834023

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

Comparison Between Bupivacaine 0.5% Versus Bupivacaine 0.25% Plus Lidocaine 1% in Ultrasound-guided Infraclavicular Block: a Prospective Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Hospital de San Carlos Dr. Benicio Arzola Medina · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators will compare two different anesthetic solutions in the infraclavicular block in patients having forearm, wrist, and hand surgery. The solutions will be bupivacaine 0.5% versus bupivacaine 0.25% plus lidocaine 1%, both associated with epinephrine 5 mcg/ml and dexamethasone 4 mg. The main objective of this investigation is to demonstrate that using higher concentrations of bupivacaine alone results in a significant block duration increase compared with the mixture of bupivacaine and lidocaine.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine-LidocaineInfraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg/ml
DRUGBupivacaineInfraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.5% + dexamethasone 4 mg + epinephrine 5 mcg/ml

Timeline

Start date
2023-05-02
Primary completion
2023-12-29
Completion
2024-01-05
First posted
2023-04-27
Last updated
2024-01-17

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT05834023. Inclusion in this directory is not an endorsement.

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block (NCT05834023) · Clinical Trials Directory